SCY-770 was well tolerated with a favorable safety profile in healthy adult participants at higher doses than previously evaluated• Phase 2 ...

I have summarized the "pathology," "treatment," and "side effects of medication."Pathology• Cyst cells proliferate abnormally ...

Four-year-old Aryia needs a kidney transplant after doctors ruled out her parents as donors.

PYC Therapeutics shares gained 5.1% as investors looked ahead to clinical data for PYC-003, an experimental RNA treatment for inherited polycystic kidney disease.

Early tumours may cause few or no symptoms, making routine screening especially important for timely treatment.

Perth-based company PYC Therapeutics will take early human data on its polycystic kidney disease drug to the American Society of Nephrology conference in Denver on 22 October.

A nephrologist argued that understanding mitochondrial dysfunction in kidney cells will have an impact on future ...

The Phase 1 study enrolled 25 healthy participants across three cohorts. The initial cohort received a single 500 mg dose under fed and fasted conditions, while subsequent cohorts received 750 mg once ...

One morning, you find the toilet bowl stained red.Surprised, you watch it for a while. The next urine is a little lighter in ...

"If you feel like you need to pee but you can’t, you need to go to the doctor..." ...

Bríd McGill from Portlaoise is taking on the Irish Life Dublin Marathon this October, running in memory of her late mother-in ...

Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD Phase 1 study is evaluating the safety, ...